presentation
Download
Report
Transcript presentation
1
Orthomyxovirus
Hugh B. Fackrell
[email protected]
Filename: orthomyx.ppt
3/21/2017
2
Orthomyxovirus Outline
Structure
Classification
Multiplication
Clinical manifestations
Epidemiology
Diagnosis
Control
Baron’s Web Site
3/21/2017
3
Structure
Influenza viruses
ssRNA, antisense,
multipartite genome, 7-8
segments, 10 genes
spherical OR filamentous
enveloped
hemagglutinin
neuraminidase
3/21/2017
4
Flu Hemagglutinin
Protein in viral envelope
13 different hemagglutinin antigens
binds to N-aceytlneuraminic acid on host
cell glycolipids or glycoproteins
Hemagglutinin hydrolysed by host cell
proteases to create infectious virion
3/21/2017
5
Flu Neuraminidase
Found in the viral envelope
9 different neuraminidase antigens
Removes N-acetylneuraminic acid from
glycolipids and glycoproteins derived from
host cell
Dissolves N-acetylneuraminic acid in
mucus to increase liquefaction
Prevents self hemagglutination
3/21/2017
6
Classification
Three antigenic types of nucleoprotein give rise
to three different strains of influenza
Flu A,
Flu
B
Flu C
No antigenic cross reactivity of nucleoproteins
3/21/2017
7
Gene Reassortment
ANTIGENIC SHIFT
Host cell is infected simultaneously with
two different strains of flu
Progeny viruses have mixture of gene
segments because RNA multipartite
Novel Type A strains
gives rise to pandemics of
influenza A
3/21/2017
8
Influenza 1918
Started in midwestern USA
Spread to Europe on troopships
Attacked healthy adults
Antigenic Shift
Trying to isolate cells with both strains of
Virus
3/21/2017
9
Antigenic Drift
Flu A Flu B undergo genetic changes in the
enveloped proteins
MINOR antigenic changes
serologically cross reactive
Causes yearly epidemics
3/21/2017
10
Influenza Subtypes
Strain Influenza A
first isolated Bangkok
Year 79
Hemagglutinin :H1, H2, H3
Neuraminidase N1, N2
A/Bangkok/79 H3N2
Link to CDC Web site
3/21/2017
11
Flu
infection
cycle
3/21/2017
12
3/21/2017
13
“Original Antigenic Sin”
Individual develops antibodies to flu
antigens after first exposure
On second exposure antigens changed
inducing a new array of antibodies
Antibodies to shared antigenic epitopes
have higher avidity
Used to identify the original infection
3/21/2017
14
Influenza Multiplication
virus binds to host by hemagglutinin
transcription & nucleocapside assembly in
nucleus
infectious virions assembled in cytoplasm
bud from cell membranes
cycle takes 6 hours
3/21/2017
15
Clinical Manifestations
Respiratory symptoms
Coryza, sore throat, cough,
substernal chest pain
Systemic Symptoms
Headache, chills, fever (3840C), prostration
3/21/2017
16
Epidemiology
Epidemic lasts 6 weeks in Jan-Feb
First in school age children (5-9 years)
Brought home to preschooler & adults
industrial
absenteeism
Pneumonia influenza in elderly
3/21/2017
17
Diagnosis
Clinical symptoms
more likely if
syndrome occurs in adults in winter
a febrile respiratory epidemic is underway
Detection of Virus
rise in antibody titre between acute phase and
convalescent phase
3/21/2017
18
Detection of Flu Virus
Isolated from respiratory secretions
grown in tissue culture
embryonated eggs
Virus identified by presence of
hemagglutinin
3/21/2017
19
Tissue culture
Hemadsorption
Red cells adhere to virions budding from
the host cell
Hemagglutination inhibition
Confirm
with serological analysis of tissue
culture fluid
3/21/2017
20
Prevention
Prevention
Influenza virus
vaccine
Treatment
Amantadine
1976 effective
against type A Web
site
Rimantadine
1993 effective against
type A & type B
Neuraminidase Inhibitors
zanamivir and oseltamivir
3/21/2017
21
Treatment
Amantadine
1976 effective against type A Web site
Rimantadine
1993
effective against type A & type B
Neuraminidase Inhibitors
1999 zanamivir and oseltamivir web Site
3/21/2017
22
Influenza virus vaccine
Developed half a century ago
virus grown in chick egg embryos
inactivated with formalin
One- doses administered pareenterally in
the fall
50-90% effective
Web site
3/21/2017
23
The national swine flu
immunization of 1976 was
accompanied by an increase risk
of Guillain-Barre syndrome
3/21/2017
24
Guillain- Barre Syndrome
AKA Acute Infectious Polyneuritis
Symptoms
symmetric
flaccid paralysis
facial paralysis
Degeneration of myelin of peripheral nerves
Allergic reaction
3/21/2017
25
Amantadine
Amantadine hydrochloride
administered for 10 days
blocks viral uncoating
prevents 50% of infections
prevents 67% of illnesses
prophylactically protects 80%
3/21/2017